Newborn screening for lymphopenia is now being done in all 50 states by measuring TRECs. This session will elucidate the evolution and meaning of this testing; benefits and limitations; and most importantly, delineate implications for practitioners. It will also provide an overview of current management of severe combined immunodeficiency (SCID).

Upon completion of this activity, participants should be able to:

  • Define and discuss newborn screening for lymphopenia via TRECs
    Describe management of the newborn with SCID
    Plan and implement the management and care of the infant with lymphopenia, secondary to etiologies other than SCID


Moderator Introduction
Larraine  L. Lyter-Reed, MSN RN FNP-BC
Baylor College of Medicine

Newborn Screening for Lymphopenia via TRECs
Vivian  P. Hernandez-Trujillo, MD FAAAAI
Allergy and Immunology Care Center of So

Management of Neonates with Lymphopenia Not Caused by Severe Combined Immunodeficiency
M. Elizabeth  M. Younger, CRNP, PhD
Johns Hopkins School of Medicine

Current Treatment and Management of the Infant with Severe Combined Immunodeficiency
William  R. Blouin, APRN
Allergy and Immunology Care Center of South Florida

Please take a moment to click the link below and give us your feedback on this session: